Abstract
Background
Elevated thyroglobulin (Tg) levels post surgery are associated with disease recurrence in papillary thyroid carcinoma (PTC). The aim of this study is to determine which clinicopathological factors influence Tg elevation following surgery and radio-iodine ablation (RAI) for PTC.
Methods
A retrospective study of consecutive patients undergoing total thyroidectomy and RAI for PTC was carried out. Prophylactic central neck dissection (CND) was performed if the diagnosis of PTC was made preoperatively. Lateral neck dissection (LND) was guided by ultrasound findings. RAI was administered 6 weeks postoperatively. Stimulated Tg levels were measured at 12 months.
Results
One hundred patients with PTC were studied. Forty patients had routine CND. The median tumour size was 15 mm. Median stimulated Tg level at 12 months was 0.3 μg/L. On multivariate analysis the number of metastatic lymph nodes removed had a significant positive association with serum Tg levels (P = 0.003). The total number of lymph nodes resected had a significant inverse relationship with serum Tg levels (P = 0.04). Tumour size, multifocality, vascular and capsular invasion did not appear to have significant correlation with Tg levels.
Conclusion
Lymph node metastases are associated with increased postablative Tg levels in PTC. More complete lymphadenectomy is associated with lowering of Tg levels.
Similar content being viewed by others
Abbreviations
- PTC:
-
Papillary thyroid carcinoma
- Tg:
-
Thyroglobulin
- RAI:
-
Radio ablative iodine-131
- TT:
-
Total thyroidectomy
- CND:
-
Central neck dissection
- LND:
-
Lateral neck dissection
- LN:
-
Lymph nodes
- CI:
-
Confidence interval
- WBS:
-
Whole-body scan.
References
Sosa J, Udelsman R. Total thyroidectomy for differentiated thyroid cancer. J Surg Oncol 2006; 94:701–7
Cooper D, Doherty G, Haugen B, et al. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:109–42
Ringel M, Ladenson P. Controversies in the follow-up and management of well-differentiated thyroid cancer. Endocrine-Related Cancer 2004; 11:97–116
Torrén J, Burch H. Serum thyroglobulin measurement. Utility in clinical practice. Endocrinol Metabol Clin North Am 2001; 30:429–67
Schlumberger M, Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol 1998; 138:249–52
Kücük O, Aras G, Kulak H, et al. Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: comparison with 99mTc-MIBI scans. Nucl Med Commun 2006; 27:873–6
Baudin E, Do Cao C, Cailleux A, et al. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metabol 2003; 88:1107–11
Ronga G, Filesi M, Ventroni G, et al. Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med 1999; 26:1448–52
Lin J, Huang M, Hsu B, et al. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. J Surg Oncol 2002; 80:45–51
Hall F, Beasley N, Eski S, et al. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma. Laryngoscope 2003; 113:77–81
Lee H, Rha S, Jo Y, et al. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma. Am J Clin Oncol 2007; 30:63–8
Bohm J, Kosma V, Eskelinen M, et al. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma. Eur J Endocrinol 1999; 141:460–7
Toubeau M, Touzery C, Arveux P, et al. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after 131I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 2004; 45:988–94
Sywak M, Cornford L, Roach P, et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006; 140:1000–7
Grodski S, Cornford L, Sywak M, et al. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 2007; 77:203–8
Clark O. Papillary thyroid carcinoma: rationale for total thyroidectomy. In: Clark O, Duh Q, Kebebew E (eds.) Textbook of Endocrin Surgery. Philadelphia: Elsevier Saunders, 2005. pp. 110–4
Sywak M, Pasieka J, Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol 2004; 86:44–54
Qubain S, Nakano S, Baba M, et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 2002; 131:249–56
Scheumann G, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994; 18:559–67
Cady B, Sedgwick C, Meissner W, et al. Risk factor analysis in differentiated thyroid cancer. Cancer 1979; 43:810–20
Lundgren C, Hall P, Dickman P, et al. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer. Br J Surg 2007; 94:571–7
Lundgren C, Hall P, Dickman P, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006; 106:524–31
Welch-Dinauer C, Tuttle R, Robie D, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol 1998; 49:619–28
Bilimoria K, Bentrem D, Ko C, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007; 246:375–84
Roelants V, Nayer P, Bouckaert A, et al. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1997; 24:722–7
Sangalli G, Serio G, Zampatti C, et al. Fine needle aspiration cytology of the thyroid: a comparison of 5469 cytological and final histological diagnoses. Cytopathology 2006; 17:245–50
Acknowledgements
We thank Pamela Edhouse and Macushla Myles for their effort in maintaining our thyroid cancer database.
Funding
Funding for establishment of a thyroid cancer database was provided through a grant from the New South Wales Cancer Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Low, TH.(., Delbridge, L., Sidhu, S. et al. Lymph Node Status Influences Follow-Up Thyroglobulin Levels in Papillary Thyroid Cancer. Ann Surg Oncol 15, 2827–2832 (2008). https://doi.org/10.1245/s10434-008-0049-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-008-0049-1